NKECHI ILEKA-ADEOYE: Open Payments
NPI 1285974451 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,582 in 32 payments from 17 companies in 2025. Trend: 2023 $821 · 2024 $654 · 2025 $2,582
Food & beverage: $2,582
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $792 |
| AstraZeneca Pharmaceuticals LP | 4 | $341 |
| ABBVIE INC. | 4 | $215 |
| Dexcom, Inc. | 1 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $112 |
| Alkermes, Inc. | 4 | $109 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| Amgen Inc. | 1 | $102 |
| Madrigal Pharmaceuticals | 1 | $97 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
Products named: Wegovy, Ozempic, BREZTRI, RINVOQ, AIRSUPRA, DEXCOM G7 GSS (161), CAPLYTA, VIVITROL.
Industry payments across MD — which companies pay providers there.
